Ποια είναι η κεφαλαιοποίηση αγοράς για Zylox-Tonbridge Medical Technology Co., Ltd. (2190)

Η κεφαλαιοποίηση αγοράς για Zylox-Tonbridge Medical Technology Co., Ltd. (2190) είναι $869.04M

Zylox-Tonbridge Medical Technology Co., Ltd. (2190) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για Zylox-Tonbridge Medical Technology Co., Ltd. (2190)

Η τιμή για Zylox-Tonbridge Medical Technology Co., Ltd. (2190) είναι $2.80

Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.

Η τιμή για 2190	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$16,938.57 $869.04M	NVDA	$5.264T	+605,613.21%
$15,128.21 $869.04M	AAPL	$4.701T	+540,875.77%
$13,441.72 $869.04M	GOOG	$4.177T	+480,567.80%
$12,283.99 $869.04M	MSFT	$3.817T	+439,168.31%
$9,223.57 $869.04M	AMZN	$2.866T	+329,729.35%

Η τιμή για 2190

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$16,938.57 $869.04M